PTTG1-mediated the transcription of c-myc promotes retinoblastoma progression. [PDF]
Feng J, Ye Y, Cheng F, Wu Y.
europepmc +1 more source
Divergent c-MYC Expression Patterns in NET and NEC: Insights from a Multicentre Cohort of 1380 Neuroendocrine Neoplasms. [PDF]
Schmitt M +22 more
europepmc +1 more source
The red box: a selective G-quadruplex binder that downregulates <i>c-MYC</i> expression in human cells. [PDF]
Novo P +5 more
europepmc +1 more source
Targeting the PDK1/c-Myc/SOX10 Signaling in Oligodendrocytes Alleviates Neuropathic Pain. [PDF]
Qiao P +7 more
europepmc +1 more source
Omacetaxine reduces c-Myc expression and demonstrates antitumor effects in osteosarcoma. [PDF]
Farrell KB, Das S, Thamm DH.
europepmc +1 more source
Inhibitory effects of c-MYC degrading rLON protease on intestinal polyps in PIRC rat, a familial adenomatous polyposis model. [PDF]
Venkatachalam K +8 more
europepmc +1 more source
Aloe-emodin inhibits nasopharyngeal carcinoma by modulating telomerase activity involving the c-Myc/E2F1 axis. [PDF]
Li M +7 more
europepmc +1 more source
PARK2 Inhibits the progression of colorectal cancer via ubiquitinating MARCKSL1 to inhibit the c-Myc pathway. [PDF]
Lin J, Cheng X.
europepmc +1 more source
Correction for Sepulveda et al., Proteolytic activation of c-MYC facilitated by DOT1L. [PDF]
europepmc +1 more source
MAGEC2 promotes tumorigenesis in multiple myeloma through USP16-mediated deubiquitination and stabilization of c-Myc. [PDF]
Liu Z +8 more
europepmc +1 more source

